Document Detail

Safety and efficacy of thrombin-JMI: a multidisciplinary expert group consensus.
MedLine Citation:
PMID:  21078609     Owner:  NLM     Status:  In-Process    
BACKGROUND: The use of bovine thrombin has been an effective approach to aiding hemostasis during surgery for over 60 years. Its use has a reported association with the development of antibodies to coagulation factors with limited evidence to the clinical significance.
METHODS: The Collaborative Delphi survey methodology was used to develop a consensus on specified topic areas from a panel of 12 surgeons/scientists who have had experience with topical thrombins; it consisted of 2 rounds of a Web-based survey and a final live discussion.
RESULTS: Some key issues that reached consensus included: bovine, human plasma-derived and recombinant human thrombin are equally effective hemostatic agents with similar adverse event rates, and immunogenicity to a topical protein rarely translate into adverse events.
CONCLUSIONS: Although a risk of immunogenicity is associated with all topical thrombins, no conclusive clinical evidence is available that these antibodies have any significant effect on short- and long-term clinical consequences.
Mohit Bhandari; Frederick A Ofosu; Nigel Mackman; Craig Jackson; Cataldo Doria; John E Humphries; Sateesh C Babu; Thomas L Ortel; David Hoffman Van Thiel; Jeanine M Walenga; Rakesh Wahi; Kevin Hong To Teoh; Jawed Fareed
Related Documents :
20024569 - Successful photodynamic therapy with topical 5-aminolevulinic acid for five cases of ce...
18795919 - Curettage treatment for molluscum contagiosum: a follow-up survey study.
9875199 - The development of practice guidelines for the treatment of severe plaque form psoriasis.
17009639 - Receptor modifications in vulvar dystrophies before and after treatment with topical ho...
2865009 - Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%.
6453849 - Treatment of acne vulgaris with topical clindamycin phosphate: a double-blind study.
19359629 - Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant ...
23503879 - Percutaneous nephrolithotomy for renal stones following failed extracorporeal shockwave...
17804769 - Angioplasty with or without stent placement in the brachiocephalic artery: feasible and...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-11-15
Journal Detail:
Title:  Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis     Volume:  17     ISSN:  1938-2723     ISO Abbreviation:  Clin. Appl. Thromb. Hemost.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508125     Medline TA:  Clin Appl Thromb Hemost     Country:  United States    
Other Details:
Languages:  eng     Pagination:  39-45     Citation Subset:  IM    
McMaster University, Hamilton, ON, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Global fibrinolytic capacity in neonatal sepsis.
Next Document:  Evaluation and treatment of neonatal thrombus formation in 17 patients.